Bionano Genomics, Inc. (BNGO) Return on equity 2018–2025
Bionano Genomics, Inc. (BNGO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-59.4%FY2025 · since FY2018: -182.5% → -59.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -59.4% | +257.2 pp |
| FY2024 | -316.7% | -74.9 pp |
| FY2023 | -241.8% | -188.6 pp |
| FY2022 | -53.2% | -31.7 pp |
| FY2021 | -21.5% | +95.7 pp |
| FY2020 | -117.2% | +708.0 pp |
| FY2019 | -825.2% | -642.8 pp |
| FY2018 | -182.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice